Esther Lim is an associate in the Palo Alto office of Wilson Sonsini Goodrich & Rosati, where she focuses on corporate and securities law and high-growth companies in the life sciences sector. She advises companies on general corporate matters, including formation and operation, corporate governance, debt and equity financings, mergers and acquisitions, and securities-related matters.
Esther Lim is an associate in the Palo Alto office of Wilson Sonsini Goodrich & Rosati, where she focuses on corporate and securities law and high-growth companies in the life sciences sector. She advises companies on general corporate matters, including formation and operation, corporate governance, debt and equity financings, mergers and acquisitions, and securities-related matters.
- J.D., University of California, Irvine School of Law, 2022Senior Diversity and Outreach Editor, UC Irvine Law Review; Executive Board Member, Women in Tech Law; Advanced Clinical Student, Intellectual Property, Arts, and Technology Clinic
- B.A., Political Science, New York University, 2016Minor in Business Studies, University Honors Scholar Graduate
- State Bar of California
- J.D., University of California, Irvine School of Law, 2022Senior Diversity and Outreach Editor, UC Irvine Law Review; Executive Board Member, Women in Tech Law; Advanced Clinical Student, Intellectual Property, Arts, and Technology Clinic
- B.A., Political Science, New York University, 2016Minor in Business Studies, University Honors Scholar Graduate
- State Bar of California
The transaction combines Natera’s leading commercial and operational infrastructure for the delivery of personalized MRD testing with Foresight’s unique phased variant technology and leadership in lymphoma. It builds on Natera’s broad intellectual property portfolio for tumor-informed and personalized MRD products including in phased variants, and promises to accelerate MRD adoption in lymphoma and other solid tumor types.
- Privacy Policy
- Terms of Use
- Accessibility